Extended Data Fig. 10: Validation of CyTOF antibodies. | Nature Immunology

Extended Data Fig. 10: Validation of CyTOF antibodies.

From: Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Extended Data Fig. 10: Validation of CyTOF antibodies.The alternative text for this image may have been generated using AI.

a, CyTOF analysis of human lymphoid aggregate cultures generated from tonsils depicting CD3+ T cells on the top and CD3 B cells on the bottom as indicated, analogous to methods previously described18. b, CyTOF analysis of PMA/ionomycin- or LPS-stimulated PBMCs, depicting CD3+ T cells on the top and CD3 cells on the bottom, similar to prior studies2,3,4,5. c, Expression of Foxp3 among CD4+ Treg cells and CD4+ TN cells, as assessed by CyTOF. d, Expression of CD30 and Ki67 among CD3+ CD45RO+CD45RACD4+ T memory (TM) cells and CD4+ TN cells, as assessed by CyTOF. ****p < 0.0001 (two-sided paired t-test). e, Illustration of pTFH gate implemented on PBMC samples, and TFH gate implemented on tonsil samples. Cells were pre-gated on CD4+ TM cells.

Back to article page